Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

AlphaRx to sublicense cancer therapeutic from Select Therapeutics

Nov. 22, 2002

Oxi-4503 compares favorably to CA4P in antivascular and antitumor activity

Nov. 21, 2002

Antitumor activity and resistance mechanisms further characterized for XR-5944 and XR-11576

Nov. 21, 2002

Phase I data for NB-1011 discussed at EORTC-NCI-AACR symposium

Nov. 21, 2002

Aventis scientists present new tubulin polymerization inhibitors

Nov. 21, 2002

Phase I/II trial initiated for LE-SN-38

Nov. 20, 2002

Preclinical and early clinical data discussed for OSI-7836 in Frankfurt

Nov. 20, 2002

FDA approves SuperGen's NDA to market Mitozytrex

Nov. 20, 2002

D-63153, a new GnRH antagonist as a candidate for sex steroid-dependent diseases

Nov. 20, 2002

Bay-43-9006 scheduled to enter phase III in 2003

Nov. 20, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...